Status:
COMPLETED
The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients
Lead Sponsor:
Indiana University
Collaborating Sponsors:
Merck Sharp & Dohme LLC
National Kidney Foundation, United States
Conditions:
Chronic Kidney Disease
Dialysis
Eligibility:
FEMALE
9-18 years
Brief Summary
The proposed study is a pilot study and a first step towards developing an optimized HPV vaccination strategy for girls who have CKD, or are on dialysis or have a kidney transplant.
Eligibility Criteria
Inclusion
- 9-18-year-old girls who have CKD stages 3 or 4 (Glomerular filtration rates 15-59 mL/min/1.73m2).
- 9-18-year-old girls who are on dialysis.
- 9-18-year-old girls who have had a functioning kidney transplant for longer than 6 months and are on the same immunosuppression regimen.
- Healthy 9-18-year-old girls
Exclusion
- Pregnancy, fever, allergy to any vaccine component, any immune disorder and any blood product received in the previous 6 months.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT00767897
Start Date
November 1 2011
End Date
December 1 2018
Last Update
March 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University/Riley Children's Hospital
Indianapolis, Indiana, United States, 46202